ArticleWorld journal of oncology2022

Prospective Cohort Study of Palbociclib Treatment in Postmenopausal Patients With Unresectable and Metastatic Hormone Receptor-Positive Breast Cancer: Study Protocol for a CSPOR-BC Palbociclib Cohort Trial.

Kazutaka Narui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.